✦ LIBER ✦

Management of Human Papillomavirus–Positive and Human Papillomavirus–Negative Head and Neck Cancer

✍ Scribed by Ranee Mehra; K. Kian Ang; Barbara Burtness

Book ID: 113900831
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 146 KB
Volume: 22
Category: Article
ISSN: 1532-9461
DOI: 10.1016/j.semradonc.2012.03.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human Papillomavirus and Head and Neck C

Human Papillomavirus and Head and Neck Cancer

✍ Laura McLaughlin; Margaret Bultas; Stephanie Shorey 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Distinct Risk Factor Profiles for Human

Distinct Risk Factor Profiles for Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Cancers

✍ Gillison, M. L.; D'Souza, G.; Westra, W.; Sugar, E.; Xiao, W.; Begum, S.; Viscid 📂 Article 📅 2008 🏛 Oxford University Press 🌐 English ⚖ 224 KB

Human papillomavirus, smoking, and head

Human papillomavirus, smoking, and head and neck cancer

✍ Parul Sinha; Henrietta L. Logan; William M. Mendenhall 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Human papillomavirus (HPV) in head and n

Human papillomavirus (HPV) in head and neck cancer

✍ Stina Syrjänen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Epidemiology of Human Papillomavirus-Rel

Epidemiology of Human Papillomavirus-Related Head and Neck Cancer

✍ Joseph, Andrew W.; D'Souza, Gypsyamber 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 511 KB

Human papillomavirus seropositivity and

Human papillomavirus seropositivity and risks of head and neck cancer

✍ Elaine M. Smith; Justine M. Ritchie; Michael Pawlita; Linda M. Rubenstein; Thoma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 115 KB 👁 2 views

## Abstract We examined antibody response to VLP HPV‐16, HPV‐16 E6 and E7 antibodies as potential seromarkers of HPV‐related head and neck cancer (HNC). The study included 204 HNC cases and 326 controls evaluated for HPV presence in sera using ELISAs for anti‐HPV VLP antibodies and HPV‐16 E6 and/or